CDH1 and breast lobular carcinoma: As expected (see also Figure 13C), CDH1 was significantly decreased in lobular carcinomas vs. ductal carcinomas in all 16q-loss groups (A, B1, and D) and was the only 16q-LvsD-DEGs that was coherently decreased in lobular carcinomas of those three groups.